Michael Leane, Kendal Pitt, Gavin Reynolds, Sune Andersen, Brian Carlin, Abina Crean, John Gamble, Michael Gamlen, Bindhu Gururajan, Yaroslav Z Khimyak, Peter Kleinebudde, Martin Kuentz, Zdravka Misic, Chris Moreton, Stefanie Peter, Stephen Sheehan, Elaine Stone, Anthony Tantuccio, Bernd Van Snick
The MCS initiative was first introduced in 2013. Since then, two MCS papers have been published: the first proposing a structured approach to consider the impact of drug substance physical properties on manufacturability and the second outlining real world examples of MCS principles. By 2023, both publications had been extensively cited by over 240 publications. This article firstly reviews this citing work and consider how the MCS concepts have been received and are being applied. Secondly, we will extend the MCS framework to continuous manufacture...
April 15, 2024: Pharmaceutical Development and Technology